Pathology
-
Vanderbilt University School of Medicine Basic Sciences adds Carterra’s LSAXT instrument to speed drug and vaccine research and advance patient care
Carterra Inc. and the Vanderbilt University School of Medicine Basic Sciences announced the addition of the Carterra LSAXT label-free interaction analysis platform to the Center for Structural Biology. Vanderbilt and Vanderbilt University Medical Center researchers will be able to discover and characterize large molecules including antibodies. Read MoreSeptember 26, 2024
-
Vanderbilt University, VUMC faculty named Highly Cited Researchers, rank in top 1 percent by citations
Experts from the Institute for Scientific Information identified 13 faculty at Vanderbilt University and Vanderbilt University Medical Center as among the top one percent of cited researchers worldwide. Read MoreDecember 6, 2022
-
Study reveals new targets to inhibit pulmonary fibrosis
An international team led by researchers at Vanderbilt University Medical Center sheds new light on the cause of pulmonary fibrosis and demonstrates a way to impede the disease. Read MoreOctober 4, 2018
-
Midgut neuroendocrine tumor prognosis
Vanderbilt investigators recommend that the presence of tumor deposits in the abdomen be included when staging midgut neuroendocrine tumors. Read MoreJanuary 6, 2017
-
Vanderbilt research finds immune cells fan flames of obesity-related inflammation
Researchers at Vanderbilt University have discovered that an unusual set of immune cells, called invariant natural killer T cells, can exacerbate obesity-related inflammation. Read MoreApril 10, 2012
-
Young stem cells counter kidney aging
Young bone marrow cells alleviate aging-related kidney changes in mice. Read MoreDecember 15, 2011
-
Virus-linked cancer gets help from host
Host cell protein may be a target for strategies to limit spread of virus-induced squamous cell cancers. Read MoreDecember 15, 2011
-
Balancing act in the gut
Vanderbilt researchers have identified an antigen important to balancing the immune response to bacteria in the gut. Read MoreNovember 11, 2011
-
Project seeks to apply gene testing to drug prescribing
The U.S. Centers for Disease Control and Prevention has awarded Vanderbilt researchers a two-year, $1 million grant to Vanderbilt to develop a model for applying genomic testing to drug prescribing in “real-world” settings. Read MoreNovember 11, 2011
-
Diversity key in antibody repertoire
Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines. Read MoreOctober 7, 2011